NBDC Research ID: hum0563.v1

 

SUMMARY

Aims: Analysis of somatic mutational burden and immune-related gene expression to elucidate the detailed mechanisms of anti-tumor immune responses.

Methods: Whole exome sequencing, RNA sequencing

Participants/Materials: gastric cancer

 

Dataset IDType of DataCriteriaRelease Date
JGAS000894 NGS (Exome, RNA-seq) Controlled-access (Type I) 2026/04/16

*Release Note

*Data users need to apply an application for Using NBDC Human Data to reach the Controlled-access Data. Learn more

 

MOLECULAR DATA

Exome

Participants/Materials

gastric cancer (ICD10: C16): 10 cases

      paired tumor and non-tumor tissues (peripheral blood): 20 samples

Targets Exome
Target Loci for Capture Methods -
Platform Illumina [NovaSeq 6000]
Library Source DNA extracted from tumor tissues and peripheral blood cells
Cell Lines -
Library Construction (kit name) SureSelect Human All Exon V6 kit
Fragmentation Methods Ultrasonic fragmentation
Spot Type Paired-end
Read Length (without Barcodes, Adaptors, Primers, and Linkers) 150 bp x 2
Japanese Genotype-phenotype Archive Dataset ID JGAD001038
Total Data Volume 325.4 GB(fastq)
Comments (Policies) NBDC policy

 

RNA-seq

Participants/Materials

gastric cancer (ICD10: C16): 9 cases

      tumor tissues:
            pre-treatment 9 samples
            after treatment 8 samples
            total 17 samples

Targets RNA-seq
Target Loci for Capture Methods -
Platform Illumina [NovaSeq 6000]
Library Source RNA extracted from tumor tissues
Cell Lines -
Library Construction (kit name) TruSeq Stranded mRNA Sample Prep Kit
Fragmentation Methods chemical fragmentation
Spot Type Single-end
Read Length (without Barcodes, Adaptors, Primers, and Linkers) 100 bp
Japanese Genotype-phenotype Archive Dataset ID JGAD001038
Total Data Volume 325.4 GB(fastq)
Comments (Policies) NBDC policy

 

DATA PROVIDER

Principal Investigator: Shohei Koyama

Affiliation: Department of Immuno genomic medicine, National Cancer Center

Project / Group Name: Macrophage Reprogramming in Gastric Cancer

Funds / Grants (Research Project Number):

NameTitleProject Number
Moonshot Research and Development Program, Japan Agency for Medical Research and Development (AMED) Actualization of a cancer-free society through regulation of chronic inflammation JP22zf0127009
Promotion of Cancer Research and Therapeutic Evolution, Japan Agency for Medical Research and Development (AMED) Development of a novel immunotherapeutic strategy with sustained therapeutic effect by modulating the priming phase JP23ama221329
Practical Research for Innovative Cancer Control, Japan Agency for Medical Research and Development (AMED) Establishment of molecular target-immune integrated therapy targeting immunosuppressive molecules on cancer cells. JP23ck0106796
National Cancer Center Research and Development Fund Establishment of specimen banking and comprehensive analysis platforms for advanced immunogenomic profiling 2024-A-03

 

PUBLICATIONS

TitleDOIDataset ID
1 Lenvatinib combined with PD-1 blockade therapy benefits gastric cancers through immunosuppressive macrophage modulation JGAD001038
2

 

USRES (Controlled-access Data)

Principal InvestigatorAffiliationCountry/RegionResearch TitleData in Use (Dataset ID)Period of Data Use